PT-141 — 10mg | Research Use Only (RUO)

Description

A synthetic melanocortin receptor agonist peptide currently being investigated in controlled laboratory environments for its interaction with central nervous system melanocortin signaling pathways.

For laboratory research use only. Not for human or animal consumption.

OVERVIEW

PT-141 (bremelanotide) is a cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone studied in preclinical models for its interaction with melanocortin receptors, specifically MC3R and MC4R. Laboratory research has examined its receptor binding selectivity, central signaling pathway activation, and comparative affinity relative to other melanocortin analogs under controlled experimental conditions.

Supplied as a lyophilized powder for analytical and experimental research applications.

PRODUCT SPECIFICATIONS

Compound: PT-141 (Bremelanotide)
Quantity: 10 mg per vial
Form: Lyophilized powder
Purity: ≥98%
Storage: -20°C recommended, protect from light
CAS: 189691-06-3

RESEARCH APPLICATIONS

– Melanocortin receptor binding and selectivity studies
– MC3R/MC4R signaling pathway analysis
– Central nervous system peptide receptor research
– Comparative melanocortin analog modeling

RESEARCH USE ONLY

This product is intended strictly for laboratory research purposes. Not for human consumption. Not for veterinary use. Not for therapeutic or diagnostic applications. Not intended to treat, cure, or prevent any condition. Use is limited to qualified professionals in controlled laboratory environments.

Certificate of Analysis available upon request.